Our diagnostic advantage comes from

instead of finding pathogens directly

READING THE IMMUNE SYSTEM

or both...

Aids to quickly identify
infections as

BACTERIAL

VIRAL

HostDx FEVER

of acute infections

Aids to quickly identify the

PRESENCE

TYPE

SEVERITY

HostDx SEPSIS

to improve diagnosis of acute infections and sepsis

(like immuno-oncology has revolutionized cancer treatment)

WE HARNESS THE IMMUNE SYSTEM

Inflammatix – Home 2017-09-13T21:06:56+00:00

Host-Response Diagnostics: A Novel Validated Approach

We ‘read’ the immune system to characterize disease. The technique works by measuring the expression levels of numerous host immune genes, and then applying proprietary Inflammatix algorithms to produce clinically actionable and timely results. Our efforts in developing diagnostic tests for acute infection and sepsis have been extensively validated and published in top-tier medical journals. Inflammatix is diligently working to launch the HostDx™ Fever and HostDx™ Sepsis tests.

Host-Response-Based Acute Infection Diagnostics for Clinics and Hospitals

Our tests are addressing significant clinical needs in acute infection and sepsis diagnosis that affect millions of people

View from the Top

Perspectives from leaders in acute infection and sepsis care

Loading...

In the News: Game Changing Impact

June 12, 2017

 New: Wanted: More Data, the Dirtier the Better

Link to story

May 24, 2017 

New: Stanford Spinout Inflammatix Developing Sepsis Diagnostic Based on Host Immune Response

Link to story (pdf)

June 6, 2016

Do You Really Need Antibiotics? This Test Can Tell.

Link to story

July 28, 2015

Interview with Tim Sweeney, MD, PhD, Co-Founder of Inflammatix

Link to Interview (begins @ 19:40)

SEE ALL NEWS

Sign Up for updates: Find out the latest news.

STAY IN THE KNOW!